Management of venous thromboembolic (VTE) disease--Part II: Treatment.
Kayser
S R
SR
D000284:Administration, Oral; D000925:Anticoagulants / Q000627:therapeutic use; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006493:Heparin / Q000737:chemistry / Q000627:therapeutic use; D006801:Humans; D013923:Thromboembolism / Q000188:drug therapy*; D015912:Thrombolytic Therapy / Q000379:methods*
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D006493:Heparin